Sort
21,453 grants matching “tuberculosis”
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR
$314,510David G Kingston · Virginia Polytechnic Inst And St Univ · U01 · FY2011 · TW
Evaluating the tuberculosis epidemic in South Africa using a novel ten-year cohort
$314,487Lesley Scott · Wits Health Consortium (Pty), Ltd · R01 · FY2023 · AI
Genetics & Clinical Cohorts
$314,487Sarah Jane Dunstan · University Of Washington · U19 · FY2022 · AI
Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB)
$314,460Barun Mathema · Columbia University Health Sciences · R01 · FY2025 · AI
Combined Amikacin and Azithromycin in an Inhaled Formulation for the Treatment of NTM
$314,363Zachary N Warnken · Via Therapeutics, Llc · R41 · FY2025 · AI
B Cells and Development of Intestinal Epithelium
$314,325Jackson Laboratory · R01 · FY2002 · AI
Pathogenesis of Infectious Diseases Training Program
$314,241Weill Medical College Of Cornell Univ · T32 · FY2004 · AI
Assay Core
$313,924Charles Arthur Peloquin · University Of Florida · P01 · FY2020 · AI
Structure and Mechanism of Metalloregulatory Proteins
$313,772David P. Giedroc · Trustees Of Indiana University · R01 · FY2010 · GM
Molecular Definition of Mycobacterium paratuberculosis
$313,753Colorado State University-Fort Collins · R01 · FY2002 · AI
Whole cell and essential enzyme screening assays for mycothiol biosynthesis
$313,672Robert C Fahey · University Of California, San Diego · R01 · FY2009 · AI
Evaluating the tuberculosis epidemic in South Africa using a novel ten-year cohort
$313,617Lesley Scott · Wits Health Consortium (Pty), Ltd · R01 · FY2024 · AI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition
$313,427Luis E Quadri · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · AI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition
$313,427Luis E Quadri · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · AI
TB-related Immune Reconstitution Syndrome in HIV-1 Infected South Africans
$313,367Livio Azzoni · Wistar Institute · R01 · FY2007 · AI
Novel Murine Studies for Optimizing Effective Short-Course TB Therapy
$313,356Arnold Louie · University Of Florida · P01 · FY2017 · AI
Improving Network Analysis and Visualization for Infectious Disease Control
$313,322Neil Franklin Abernethy · University Of Washington · R01 · FY2014 · LM
An integrated NMR/magnetic nanosensor system for detection of bacteria and toxins
$313,178J Manuel Perez · University Of Central Florida · R01 · FY2009 · GM
Functions and Mechanisms of M. Tuberculosis S/T Kinases
$313,170Thomas C Alber · University Of California Berkeley · R01 · FY2009 · GM
Clinical Development of SQ109 for H. pylori Infection
$313,110Lisa Beth Ferstenberg · Sequella, Inc. · R21 · FY2012 · DK
Gene Expression in Mycobacterium Tuberculosis
$312,886Josephine E Clark-Curtiss · Arizona State University-Tempe Campus · R01 · FY2008 · AI
Gene Expression in Mycobacterium Tuberculosis
$312,886Josephine E Clark-Curtiss · Arizona State University-Tempe Campus · R01 · FY2009 · AI
Protein-Derived Cofactor in Bifunctional Enzyme KatG from Mycobacterium tuberculosis
$312,854Aimin Liu · University Of Texas San Antonio · R01 · FY2025 · GM
Pathway analysis of tuberculosis pathogenesis
$312,829Catherine Marie Stein · Case Western Reserve University · R01 · FY2013 · HL
Clinical Research Products Management Center (CRPMC)
$312,626Carina Rerngsamai-Nhe · Fisher Bioservices, Inc. · N01 · FY2022 · AI